Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Artery Infusion”

279 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 279 results

Not applicableStudy completedNCT06199297
What this trial is testing

Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 188
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07570914
What this trial is testing

Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Cancer Liver Metastases (CRLM)Colorectal CancerLiver Metastasis
Tianjin Medical University Cancer Institute and Hospital 28
Not applicableLooking for participantsNCT05713994
What this trial is testing

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Ze-yang Ding, MD 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT03869034
What this trial is testing

HAIC Combined with PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 40
Not applicableUnknownNCT00522509
What this trial is testing

Preoperative Hepatic Arterial Infusion Chemotherapy

Who this might be right for
Colorectal Liver Metastases
IRCCS San Raffaele
Testing effectiveness (Phase 2)Study completedNCT05166239
What this trial is testing

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Thrombosis
Peking University 66
Testing effectiveness (Phase 2)UnknownNCT05311319
What this trial is testing

HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection

Who this might be right for
Hepatocarcinoma
Fudan University 70
Testing effectiveness (Phase 2)UnknownNCT00852228
What this trial is testing

Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy

Who this might be right for
Metastatic Colorectal CancerLiver MetastasesHepatic Lesions
Association pour la Recherche sur le Temps Biologique et la Chronothérapie 60
Testing effectiveness (Phase 2)UnknownNCT05886465
What this trial is testing

HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 40
Testing effectiveness (Phase 2)UnknownNCT06364007
What this trial is testing

HAIC Combined With Durvalumab and Tremelimumab and Lenvatinib in uHCC

Who this might be right for
Hepatocellular Carcinoma
Sulai Liu 20
Testing effectiveness (Phase 2)UnknownNCT06001567
What this trial is testing

Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC

Who this might be right for
ThrombocytopeniaHepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 30
Testing effectiveness (Phase 2)UnknownNCT04003792
What this trial is testing

Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM.

Who this might be right for
Liver Metastasis Colon Cancer
Rabin Medical Center 49
Not applicableUnknownNCT05233358
What this trial is testing

HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure

Who this might be right for
Hepatocellular Carcinoma
The Central Hospital of Lishui City 176
Not applicableStudy completedNCT06435013
What this trial is testing

Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC

Who this might be right for
Hepatocellular CarcinomaLenvatinib
Sun Yat-sen University 208
Testing effectiveness (Phase 2)Looking for participantsNCT07764497
What this trial is testing

Hepatic Arterial Infusion Chemotherapy in Patients With Inoperable Colorectal Cancer Liver Metastasis

Who this might be right for
Colorectal Adenocarcinoma Metastatic in the LiverLiver Metastasis Colon CancerLiver Metastases From Colorectal Cancer+1 more
Sunnybrook Health Sciences Centre 200
Testing effectiveness (Phase 2)Study completedNCT00063960
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 94
Testing effectiveness (Phase 2)Study completedNCT05003700
What this trial is testing

Hepatic Arterial Infusion Combined With Lenvatinib and Camrelizumab for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Nanfang Hospital, Southern Medical University 39
Not applicableUnknownNCT02631564
What this trial is testing

Safety of TACE With Oxaliplatin, Irinotecan and Raltitrexed for Refractory Colorectal Cancer Liver Metastasis

Who this might be right for
Colon Cancer Liver Metastasis
Fudan University 200
Not applicableLooking for participantsNCT07466238
What this trial is testing

HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
Peking University 40
Testing effectiveness (Phase 2)Study completedNCT00004142
What this trial is testing

Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
M.D. Anderson Cancer Center 40
Next Page